GlaxoSmithKline CR`s Non-Current Assets reached 10.1 CZK mil in 2017. This is 37.4 % less than in the previous year.
Buy Non-Current Assets data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | 6.77 | 5.13 | 4.91 | 2.67 | 1.43 | ||||||||
| Bayer Czech Republic | CZK mil | ... | ... | ... | 70.6 | 30.5 | 17.1 | 15.2 | 16.1 | ||||||||||
| GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | 41.0 | 57.7 | 47.5 | 33.7 | 18.8 | ||||||||||
| Merck Czech Republic | CZK mil | ... | ... | 10.1 | 9.11 | 8.11 | 5.62 | 6.32 | |||||||||||
| Novartis Czech Republic | CZK mil | 12.0 | 23.4 | 34.3 | 34.3 | 55.3 | |||||||||||||
| Pfizer Czech Republic | CZK mil | ... | ... | 16.5 | 9.46 | 7.30 | 99.1 | 197 | |||||||||||
| Roche Czech Republic | CZK mil | ... | ... | ... | 329 | 354 | 338 | 334 | 319 | ... | |||||||||
| Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | 46.9 | 51.1 | 45.0 | 36.7 | 34.3 | |||||||||
| Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 3.08 | 4.16 | 6.95 | 7.98 | ||
| Walmark | CZK mil | ... | ... | ... | 700 | 621 | 794 | 747 | 1,156 |
Helgi Library 
